2-Nitro-8,9-dihydro-5H-benzo[7]annulen-7(6H)-one → (1S,2S,3R,4R)-3-[5-Chloro-2-(7-hydroxy-6,7,8,9-tetrahydro-5H-benzocyclohepten-2-ylamino)-pyrimidin-4-ylamino]-bicyclo[2.2.1]hept-5-ene-2-carboxylic acid amide

HRID 1041225노트

반응식

HRID 1041225 반응식
[NH2:1][C:2]1[CH:3]=[CH:4][C:5]2[CH2:11][CH2:10][CH:9]([OH:12])[CH2:8][CH2:7][C:6]=2[CH:13]=1.ClC1N=C(NC2C=CC=CC=2C2N(C)C=CN=2)C(Cl)=CN=1.Cl[C:36]1[N:41]=[C:40]([NH:42][C@@H:43]2[C@@H:48]3[CH2:49][C@@H:45]([CH:46]=[CH:47]3)[C@@H:44]2[C:50]([NH2:52])=[O:51])[C:39]([Cl:53])=[CH:38][N:37]=1.[N+](C1C=CC2CCC(=O)CCC=2C=1)([O-])=O>>[Cl:53][C:39]1[C:40]([NH:42][C@@H:43]2[C@@H:48]3[CH2:49][C@@H:45]([CH:46]=[CH:47]3)[C@@H:44]2[C:50]([NH2:52])=[O:51])=[N:41][C:36]([NH:1][C:2]2[CH:3]=[CH:4][C:5]3[CH2:11][CH2:10][CH:9]([OH:12])[CH2:8][CH2:7][C:6]=3[CH:13]=2)=[N:37][CH:38]=1

참가 물질

5

반응물 4

HCID 457903192-Nitro-8,9-dihydro-5H-benzo[7]annulen-7(6H)-oneHCID 57522618HCID 57522618, 화합물HCID 672635032-Amino-6,7,8,9-tetrahydro-5H-benzocyclohepten-7-ol2회HCID 86633891(2,5-Dichloro-pyrimidin-4-yl)-[2-(1-methyl-1H-imidazol-2-yl)-phenyl]-amine

생성물 1

HCID 67264345(1S,2S,3R,4R)-3-[5-Chloro-2-(7-hydroxy-6,7,8,9-tetrahydro-5H-benzocyclohepten-2-ylamino)-pyrimidin-4-ylamino]-bicyclo[2.2.1]hept-5-ene-2-carboxylic acid amide

실험 절차

Prepared analogously to Example 216d replacing 3-Ethyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-ylamine with 2-Amino-6,7,8,9-tetrahydro-5H-benzocyclohepten-7-ol and (2,5-Dichloro-pyrimidin-4-yl)-[2-(1-methyl-1H-imidazol-2-yl)-phenyl]-amine was replaced with (1S,2S,3R,4R)-3-(2,5-Dichloro-pyrimidin-4-ylamino)-bicyclo[2.2.1]hept-5-ene-2-carboxylic acid amide. 2-Amino-6,7,8,9-tetrahydro-5H-benzocyclohepten-7-ol is a byproduct from the reductive amination of 2-Nitro-5,6,8,9-tetrahydro-benzocyclohepten-7-one with various amines. The reaction was carried out in the presence of the desired reductive amination product to provide a crude mixture of amino and alcohol products. The crude mix was then reduced and a mixture of amino and alcohol products were used in the synthesis of target compounds. The mixture was then purified by prep HPLC to afford the desired amino compound as well as (1S,2S,3R,4R)-3-[5-Chloro-2-(7-hydroxy-6,7,8,9-tetrahydro-5H-benzocyclohepten-2-ylamino)-pyrimidin-4-ylamino]-bicyclo[2.2.1]hept-5-ene-2-carboxylic acid amide. LC/MS (ESI): 440.22. 1H NMR (400 MHz, DMSO, d6) δ 9.12 (s, 1H), 7.93 (s, 1H), 7.78 (s, 1H), 7.69 (m, 1H), 7.46 (m, 2H), 7.26 (s, 1H), 6.97 (d, 1H, J=8.08 Hz), 6.35 (m, 1H), 6.27 (m, 1H), 4.58 (m, 1H), 4.15 (m, 1H), 3.72 (m, 1H), 3.31 (s, 2H), 2.88 (s, 1H), 2.78 (m, 3H), 2.11 (d, 1H, J=8.59 Hz), 1.89 (m, 2H), 1.41 (d, 1H, J=8.09 Hz), 1.33 (m, 2H).

후처리

  1. customPrepared analogously to Example 216d
  2. customto provide a crude
  3. additionThe crude mix
  4. customwere used in the synthesis of target compounds
  5. customThe mixture was then purified by prep HPLC

출처 및 근거

ORD 기록
ord-95bf4c12593b413fa7657648e7992883
출처 데이터셋
uspto-grants-2013_10
특허 번호
US08552186B2

반응 노트

불러오는 중…